Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-01-09

FDA Approved: ALPRAZOLAM — Original Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved ALPRAZOLAM from Par Health USA, LLC under ANDA078088. It represents a generic version of alprazolam for the treatment of anxiety disorders and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

ORIG AP for ALPRAZOLAM (ALPRAZOLAM)